Immunology and immunotherapy of human cancer: present concepts and clinical developments

被引:50
作者
Bremers, AJA [1 ]
Parmiani, G [1 ]
机构
[1] Ist Nazl Studio & Cura Tumori, Unit Immunotherapy Human Tumours, I-20133 Milan, Italy
关键词
immunology; immunotherapy; human cancer;
D O I
10.1016/S1040-8428(99)00059-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immunotherapy of cancer is entering into a new phase of active investigation both at the pre-clinical and clinical level, This is due to the exciting developments in basic immunology and tumour biology that have allowed a tremendous increase in our understanding of mechanisms of interactions between the immune system and tumour cells, This review briefly summarizes the state of the art in basic tumour immunology before discussing the clinical applications of the new concepts in the clinical setting, Clinical approaches are diverse but can now be based on strong scientific rationales, The analysis of the available clinical results suggests that, despite some disappointments, there is room for optimism that both active immunotherapy (vaccination) and adoptive immunotherapy may soon become part of the therapeutic arsenal to combat cancer in a more efficient way, (C) 2000 Elsevier Science Ireland Ltd, All rights reserved.
引用
收藏
页码:1 / 25
页数:25
相关论文
共 228 条
[31]   RECENT ADVANCES IN THE STUDY OF DENDRITIC CELLS AND FOLLICULAR DENDRITIC CELLS [J].
CAUX, C ;
LIU, YJ ;
BANCHEREAU, J .
IMMUNOLOGY TODAY, 1995, 16 (01) :2-4
[32]   Origin, maturation and antigen presenting function of dendritic cells [J].
Cella, M ;
Sallusto, F ;
Lanzavecchia, A .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) :10-16
[33]   Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanoma [J].
Chakraborty, NG ;
Sporn, JR ;
Tortora, AF ;
Kurtzman, SH ;
Yamase, H ;
Ergin, MT ;
Mukherji, B .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 47 (01) :58-64
[34]   A phase II trial of interleukin-2 and interferon-alpha in the treatment of metastatic colorectal carcinoma [J].
Chang, AE ;
Cameron, MJ ;
Sondak, VK ;
Geiger, JD ;
VanderWoude, DL .
JOURNAL OF IMMUNOTHERAPY, 1995, 18 (04) :253-262
[35]  
CHANG MH, 1997, NEW ENGL J MED, V336, P1959
[36]   Anti-GD2 antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age [J].
Cheung, NKV ;
Kushner, BH ;
Cheung, IY ;
Kramer, K ;
Canete, A ;
Gerald, W ;
Bonilla, MA ;
Finn, R ;
Yeh, SJ ;
Larson, SM .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (09) :3053-3060
[37]  
Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO
[38]  
2-5
[39]   Why are dendritic cells central to cancer immunotherapy? [J].
Colaco, CALS .
MOLECULAR MEDICINE TODAY, 1999, 5 (01) :14-17
[40]  
COLEY W, 1896, B J HOPKINS HOSP, V7, P157